Abstract
Background Emotional dysregulation constitutes a serious public health problem in need of novel transdiagnostic treatments. To this aim, we developed and tested a one-time intervention that integrates behavioral skills training with concurrent repetitive transcranial magnetic stimulation (rTMS).
Methods Forty-seven adults who met criteria for at least one DSM-5 disorder and self-reported low use of cognitive restructuring (CR) were enrolled in a randomized, double-blind, placebo-controlled trial. Participants were taught CR and underwent active or sham rTMS applied at 10 Hz over the right or left dorsolateral prefrontal cortex (dlPFC) while practicing reframing and emotional distancing in response to autobiographical stressors.
Results Those who received active as opposed to sham rTMS exhibited enhanced regulation (ds = 0.20 - 0.67) and reduced distress (ds = 0.32 - 0.35), as measured by self-report and psychophysiological indices during the intervention (higher high-frequency heart rate variability, lower regulation duration) and ambulatory self-report measures during the week following the intervention. All participants improved in their use of reappraisal (d = 2.25), psychopathology (d = 0.48) and emotional dysregulation (d = 0.81) and maintained their gains at the one month follow up. The procedures were acceptable and feasible with few side effects. A secondary analysis suggested that participants with stress disorders may respond particularly well to active right rTMS.
Conclusion These findings show that engaging frontal circuits simultaneously with cognitive skills training and rTMS is clinically feasible, well-tolerated and shows promise as the next generation of treatments for transdiagnostic emotional dysregulation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT02573246
Funding Statement
This research and the completion of the manuscript were supported by a Brain and Behavior Young Investigator Award, a Duke internal award, and KL2 award granted to the first author and by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number 5KL2TR001115.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Duke University Health System Institutional Review Board Reviewed and approved the presented protocol
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data on the present paper were also presented as part of several conference talks. This research and the completion of the manuscript were supported by a Brain and Behavior Young Investigator Award, a Duke internal award, and KL2 award granted to the first author and by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number 5KL2TR001115. The authors have no conflicts of interest to declare. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors would like to thank the participants and to acknowledge Lisalynn Kelley, Zach Rosenthal, PhD, Caitlin Fang, PhD, Kevin Haworth, PhD, Megan Renna, PhD, Paul Geiger, PhD, Simon Davis, PhD, Moria Smoski, PhD, Tim Strauman, PhD, Michael Babyak, PhD our research assistants and DUHS staff for their contributions.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.